Insights identify opportunities to optimize sponsor, CRO, and site collaborations.
Zachary Smith
Advertisement
Assistant Director, Data Sciences and Analytics, with Tufts Center for the Study of Drug Development (Tufts CSDD)
Articles by Zachary Smith
Pilot study seeks to validate new and more granular outsourcing model classifications in differentiating performance across custom contract-service approaches.
Tufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.
2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
3
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
4
Building Broader Investigator Networks to Advance Global Breast Cancer Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
